Dr. Subudhi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161Fax+1 212-746-6692- Is this information wrong?
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2009 - 2013
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2007 - 2009
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2007
Certifications & Licensure
- FL State Medical License 2021 - Present
- TX State Medical License 2013 - 2025
- GA State Medical License 2023 - 2024
- LA State Medical License 2023 - 2024
- TN State Medical License 2023 - 2024
- WA State Medical License 2023 - 2024
- OK State Medical License 2020 - 2024
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Clinical Trials
- Neoadjuvant Listeria or Daratumumab in Prostate Cancer Start of enrollment: 2017 Mar 01
- Durvalumab and Tremelimumab in Treating Chemotherapy Naive Patients With Metastatic Castration-Resistant Prostate Cancer Start of enrollment: 2017 Jul 14
Publications & Presentations
PubMed
- Integrative molecular analyses of the MD Anderson prostate cancer patient-derived xenograft (MDA PCa PDX) series.Nicolas Anselmino, Estefania Labanca, Peter D A Shepherd, Jiabin Dong, Jun Yang, Xiaofei Song, Subhiksha Nandakumar, Ritika Kundra, Cindy J Lee, Nikolaus Schultz, Jian...> ;Clinical Cancer Research. 2024 Mar 15
- Development of a Strategic Initiative at MD Anderson Cancer Center to Improve Outcomes in Immune-Related Adverse Events.Fayle, S., Siddiqui, B., Spelman, A., Sun, M., Marble, B., Palaskas, N., McQuade, J., Lin, J., Subudhi, S., Patel, A., Jenq, R., Shah, A., Wang, Y.> ;Journal of the National Comprehensive Cancer Network. 2024 Jan 8
- Evaluation of the Aggressive-Variant Prostate Cancer Molecular Signature in Clinical Laboratory Improvement Amendments (CLIA) Environments.Slack-Tidwell, R., Zhu, K., San Lucas, F., Siddiqui, B., Soundararajan, R., Viscuse, P., Zhang, M., Rohra, P., Konnick, E., Pilie, P., Logothetis, C., Corn, P., Subudh...> ;Cancers. 2023 Dec 14
- Join now to see all
Journal Articles
- Author Correction: Fecal Microbiota Transplantation for Refractory Immune Checkpoint Inhibitor-Associated ColitisMatthew T Campbell, Jennifer A Wargo, John R Stroehlein, Padmanee Sharma, Sumit K Subudhi, Gottumukkala S Raju, Jianjun Gao, Alexander J Lazar, Dipen M Maru, Michael T..., Nature
- Fecal Microbiota Transplantation for Refractory Immune Checkpoint Inhibitor-Associated ColitisJohn R Stroehlein, Sumit K Subudhi, Jennifer A Wargo, Dipen M Maru, Gottumukkala S Raju, Jianjun Gao, Matthew T Campbell, Michael T Tetzlaff, Padmanee Sharma, Nature
- Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human CancersAntoni Ribas, Jennifer A Wargo, Sumit K Subudhi, Padmanee Sharma, Clinical Cancer Research
Press Mentions
- Portage Biotech Hosting Key Opinion Leader Event on Targeting the Adenosine Pathway in CancerFebruary 28th, 2023
- ASCO21 Preview - Equity: Every Patient. Every Day. EverywhereMay 27th, 2021
- Prostate Cancer Awareness Month: 2020 Immunotherapy Research UpdatesSeptember 3rd, 2020
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- University of Texas M.D. Anderson Cancer CenterHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: